Related Experiment Video
Updated: Feb 11, 2026
10:04
Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
19.9K
Ligand-Triggered Structural Changes in the M2 Muscarinic Acetylcholine Receptor
Mireia Jiménez-Rosés1, Minos-Timotheos Matsoukas2, Gianluigi Caltabiano1
1Laboratori de Medicina Computacional, Unitat de Bioestadística , Facultat de Medicina, Universitat Autònoma de Barcelona , 08193 Bellaterra , Spain.
Journal of Chemical Information and Modeling
|April 20, 2018
Summary
Molecular dynamics simulations reveal the muscarinic M2 acetylcholine receptor
Area of Science:
- Pharmacology
- Biochemistry
- Molecular Biology
Background:
- The muscarinic M2 acetylcholine receptor is a G-protein coupled receptor (GPCR) crucial for various physiological processes.
- Understanding GPCR activation and allosterism is vital for drug development.
- The M2 receptor offers a unique system due to available crystal structures in multiple states.
Purpose of the Study:
- To investigate the deactivation mechanism of the M2 acetylcholine receptor using molecular dynamics simulations.
- To elucidate the conformational changes induced by the inverse agonist QNB.
- To evaluate the impact of a positive allosteric modulator (LY2119620) on receptor conformation.
Main Methods:
- Extensive molecular dynamics (MD) simulations totaling 14 microseconds.
- Analysis of conformational changes in the M2 receptor structure (PDB ID: 4MQS).
- Simulations involved replacing an agonist with an inverse agonist and studying modulator effects.
Main Results:
- Identified a sequential deactivation pathway: transmission switch rearrangement, extracellular opening, and intracellular closure.
- The inverse agonist QNB triggers specific conformational changes leading to receptor deactivation.
- The positive allosteric modulator LY2119620 restricts key residues (Trp422, Tyr426) in the binding pocket.
Conclusions:
- The study elucidates the step-by-step molecular mechanism of M2 receptor deactivation.
- Ligand-specific interactions dictate the receptor's conformational transitions.
- Allosteric modulators can fine-tune receptor activity by altering specific residue conformations.
Related Concept Videos
01:25Cholinergic Receptors: Muscarinic
5.2K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.2K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
1.8K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.8K
01:31Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
00:49Ligand Binding and Linkage
5.6K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
02:51Metal-Ligand Bonds
24.5K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.5K
01:03Olfactory Receptors: Location and Structure
11.9K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
11.9K